Doctor-to-Doctor Dental Transition: A Sell-Side Guide

Table of Contents

Doctor-to-Doctor Dental Transition: A Sell-Side Guide

Key Takeaways

  • A doctor-to-doctor dental transition sells a premier practice directly to another dentist and can support full asking price, cultural continuity, and legacy protection when backed by professional sell-side advocacy.

  • Most owners choose either a walk-away sale, with a full exit after a short 4–8 week work-back, or a partnership / vest-out structure that transfers ownership gradually over several years.

  • Creating competition among multiple buyers can be one of the main factors in maximizing sale value. Practices sold through a structured, competitive process achieve final values averaging 50% above initial unsolicited offers.

  • McLerran’s CPA-led EBITDA analysis and side-by-side private-buyer versus DSO comparison provide diligence-grade valuations that often hold up under scrutiny and can reduce the risk of post-offer renegotiation.

  • Schedule a free, confidential discovery call with McLerran & Associates to receive an objective valuation and see which transition path may align with your goals.

Compare Your Doctor-to-Doctor Transition Models

Premier practice owners considering a doctor to doctor dental transition typically choose between two structures: a walk-away sale and a partnership or vest-out arrangement. Each model affects your timeline, post-close work obligations, cash received at closing, and the legacy outcomes that matter after decades of building your practice.

A walk-away sale transfers 100% ownership to a buying dentist at closing. The seller usually works back for a short period, commonly 4 to 8 weeks, to introduce patients to the incoming doctor and transfer key relationships, then exits. Average patient attrition following a well-handled transition can remain under 10% when the post-closing role is clearly defined in the employment agreement.

A partnership or vest-out suits larger practices that can support two or more doctors. The seller transfers roughly 50% ownership now to a future partner, who purchases the remaining share over time. This structure can span several years and often fits owners who want to reduce their clinical load gradually rather than exit all at once. The table below highlights how these two paths differ across timeline, work obligations, cash timing, and legacy outcomes, which can be four of the main dimensions that shape which model fits your goals.

Dimension

Walk-Away Sale

Partnership / Vest-Out

Typical timeline to close

6–9 months from listing

3–10 years for full transfer

Post-close work-back

~4–8 weeks (McLerran standard)

Ongoing, seller reduces chair time gradually

Cash at close

Full purchase price at closing

Partial proceeds now, remainder over vest period

Legacy outcomes

Clean handoff to a peer clinician, strong cultural continuity

Seller shapes successor directly over time, very high continuity potential

Valuation methodology also differs by buyer type. For doctor-to-doctor transactions, practices are commonly valued using a percentage of annual gross collections or a Seller’s Discretionary Earnings (SDE) multiple. SDE means the total financial benefit available to a single owner-operator after adding back the owner’s compensation and discretionary expenses. In 2026, private doctor-to-doctor sales of general dental practices typically range from 65% to 85% of annual gross collections, with the lower end applying to high-overhead or owner-dependent practices and the upper end to associate-driven, metropolitan practices.

Use Competition and Valuation to Strengthen Your Position

The decision to create competition among buyers can be more consequential than the decision about which buyer to accept. A practice owner usually sells once in a lifetime, while sophisticated buyers negotiate deals regularly. Without competitive tension, the buyer often sets the price.

McLerran & Associates builds every engagement on a CPA-led EBITDA analysis. EBITDA means earnings before interest, taxes, depreciation, and amortization, normalized to reflect true practice profitability after replacing the owner’s clinical labor at a market-rate associate wage. This diligence-grade work is completed before the practice goes to market, so the valuation is more likely to hold up when buyers scrutinize it and the deal is less likely to be renegotiated downward later. Practices sold through a structured multiple-buyer process achieve final sale values averaging 50% above initial unsolicited offers, which shows how process design can matter as much as the asking price itself.

At McLerran & Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.
At McLerran & Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.

For doctor-to-doctor transactions, McLerran draws on the largest premier private-buyer pool in the country, with thousands of pre-qualified individual dentists sourced through relationships with study clubs, dental organizations, and practice-finance lenders. This same infrastructure supports owners who want to explore both paths simultaneously. McLerran runs a structured auction-like bid process for DSO buyers, typically spanning 45 to 60 days and generating around 10 offers from vetted, well-backed platforms. Because the firm pre-screens all institutional buyers and blacklists poorly run DSOs, only credible offers reach the table, which allows a direct comparison between DSO bids and the private-buyer market without wasting the seller’s time on unqualified suitors.

Because McLerran works both paths in roughly equal measure, with an approximately 50/50 split between private-buyer and DSO transactions, it can deliver a genuine side-by-side valuation that quantifies a practice’s worth in both markets. Single-lane brokers usually cannot offer this comparison.

Protect Legacy with the Right Handoff and Buyer Fit

Price represents only one dimension of a successful transition. Fit also matters, which means finding a buyer whose clinical philosophy, management approach, and long-term intentions align with what the selling doctor wants for patients and staff after they leave.

For walk-away sales, the post-close work-back period is typically 4 to 8 weeks. During this window, the seller introduces patients to the incoming doctor, transfers specialist referral relationships, and supports the buyer’s insurance recredentialing process, which can take 60 to 180 days. A clearly defined post-closing employment agreement that specifies working days, hours, compensation structure, and a fixed end date can protect goodwill and help minimize patient attrition.

Staff continuity serves as a core criterion in McLerran’s buyer-screening process, not an afterthought. The firm acts as a buffer between seller and buyer throughout the transaction, which can protect the relationships and momentum that make a practice valuable.

McLerran & Associates team: McLerran is the nation's largest dental-specific sell-side M&A advisory and brokerage firms
McLerran & Associates team: McLerran is the nation’s largest dental-specific sell-side M&A advisory and brokerage firms

For owners weighing DSO affiliation, some platforms operate as “invisible” structures that preserve the existing brand, team, and clinical protocols so that patients and staff experience no visible change. Others integrate operations within 12 to 24 months of closing. Understanding which model a buyer uses forms a material part of evaluating any offer, and McLerran’s team focuses on that distinction.

Talk to McLerran’s team about your practice’s legacy priorities and how buyer sourcing can be structured around them.

A chat at McLerran & Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.
A chat at McLerran & Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.

Compare Private-Buyer and DSO Economics

The economic difference between a private-buyer sale and a DSO affiliation can be substantial, and the direction can vary by practice. For practices in the $1 million to $1.5 million revenue range, a well-run doctor-to-doctor process can deliver full asking price with a clean exit and minimal post-close obligations. For larger practices with strong EBITDA margins, institutional buyers may offer materially higher headline valuations, although those figures often include rollover equity, earnouts, and multi-year employment requirements that reduce actual cash received at closing.

Rollover equity, which sometimes represents up to 40% of a DSO deal’s total value, means the seller is effectively investing in the DSO’s future performance. That equity can appreciate significantly at a recapitalization event, or it can underperform if the platform struggles. In the first half of 2026, two large DSO platforms, Dental Care Alliance and Affordable Care, entered restructuring agreements with creditors, which serves as a reminder that not all equity is equal. McLerran helps owners review a DSO’s profitability, leadership, and financial backing before accepting any equity component. The table below compares the structural differences between private-buyer and DSO transactions across several dimensions that can directly affect net proceeds and post-close obligations.

Dimension

Private Buyer (Doctor-to-Doctor)

DSO / Institutional Buyer

Valuation method

Percentage of gross collections or SDE multiple (see ranges discussed earlier)

4.5x–8x+ EBITDA (scale-dependent)

Typical timeline to close

Similar to standard 6–9 month process

Often 9–18 months

Post-close work-back

Short walk-away period or multi-year vest-out, depending on structure

Typically 36–60 months under employment agreement

Cash vs. equity at close

Predominantly cash, straightforward asset purchase

Mix of cash, rollover equity, and earnout. Equity can represent 20%–40% of deal value

This competitive advantage, discussed earlier in the context of multiple-buyer processes, connects directly to McLerran’s transaction rate of approximately 85% to 90%, compared to an industry norm closer to 35% to 40% and do-it-yourself close rates as low as 15% to 20%. Those figures illustrate what a structured, competitive process with diligence-grade underwriting can deliver.

Frequently Asked Questions

What is the typical work-back period for a walk-away doctor-to-doctor sale?

For a straightforward walk-away sale, McLerran’s standard work-back period is approximately 4 to 8 weeks. During this time, the selling doctor introduces patients to the incoming dentist, transfers specialist referral relationships, and supports the buyer’s insurance recredentialing process. The post-closing employment agreement should specify working days, hours, compensation, and a fixed end date to protect goodwill and minimize patient attrition. Practices with higher owner dependency, where the selling doctor produces the large majority of clinical revenue, may benefit from a slightly longer handoff to reduce the risk of patient loss.

How do I know whether a private buyer or a DSO will offer me more?

The answer depends on your practice’s size, profitability, and structure. Practices in the $1 million to $1.5 million revenue range often fit the doctor-to-doctor path well, where a well-run competitive process can deliver full asking price. Larger practices with strong EBITDA margins may attract institutional buyers willing to pay higher headline multiples, although those offers frequently include rollover equity and multi-year employment requirements that reduce actual cash at close. Because McLerran works both paths in roughly equal measure, the firm produces a genuine side-by-side valuation quantifying your practice’s worth in both markets, so you can compare real after-tax outcomes rather than headline numbers.

What makes a “free” valuation risky?

A free valuation is typically a back-of-the-napkin estimate used as a lead-generation tool rather than a defensible financial analysis. When a buyer’s due-diligence team scrutinizes the numbers, a weak valuation often gets renegotiated significantly downward. McLerran’s CPA-led EBITDA analysis is diligence-grade work completed before the practice goes to market, with every add-back documented and every assumption explained. That foundation can reduce re-trading and help protect the agreed value through to closing. In one case, a free valuation placed a practice at $2.5 million, while McLerran valued it at $4.5 million and it sold for $5.25 million after a competitive process.

What factors can influence the multiple my practice receives?

Multiples are driven by fundamentals, not a fixed table. Key factors that can influence where a practice lands within a valuation range include EBITDA margin, practice size and scalability, the degree of owner dependency, hygiene revenue as a share of total collections, payer mix, lease terms, and whether a trained management team is in place. Specialty also plays a role, because different dental specialties attract different levels of buyer demand and can command different ranges. Your specific multiple comes from your specific numbers and market, which is what a professional valuation quantifies.

Do I have to keep working after I sell?

Your post-sale work commitment depends on the path you choose. In a doctor-to-doctor walk-away sale, the work-back is typically 4 to 8 weeks before the seller exits. In a partnership or vest-out structure, the seller reduces clinical involvement gradually over a period of years. In a DSO affiliation, a multi-year employment agreement, commonly three to five years, is standard, although the terms vary by buyer and deal structure. McLerran’s first step is to understand your “why” before recommending any path and to negotiate post-close obligations that align with your personal and financial goals rather than defaulting to whatever the buyer proposes.

Next Step: Get an Objective Valuation

A doctor to doctor dental transition can support full asking price, cultural continuity, and meaningful legacy protection when it is executed with professional sell-side advocacy and a valuation that holds up under scrutiny. McLerran & Associates has guided dentists through approximately 2,000 successful practice sales totaling roughly $2 billion in closed transaction volume, with a transaction rate of approximately 85% to 90%. The firm works both the private-buyer and DSO paths in equal measure, so every client receives a genuine side-by-side comparison rather than a single-lane recommendation.

Schedule a free, confidential discovery call with McLerran & Associates to discuss your practice, your goals, and your options. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us.

Owners who are not ready to commit to a process yet can consider the McLerran M&A Summit, scheduled for October 29–30, 2026, and built for owners who have not decided to sell. Attend to learn deal structures, EBITDA fundamentals, and the DSO and private-equity landscape before committing to anything, and receive a complimentary practice valuation, a $2,500 value, along with 4 CE credits. Claim your complimentary $2,500 valuation and reserve your seat today.

Get In Touch